Master The Supreme Court limited private Rule 10b-5 liability for secondary actors by holding that investors must have relied on each defendant's own public deceptive conduct or statements. with this comprehensive case brief.
Stoneridge Investment Partners v. Scientific-Atlanta is a cornerstone Supreme Court decision narrowing the scope of private securities fraud actions under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. The case addresses whether investors can sue non-issuer business partners—here, a supplier and a customer of the issuer—for their role in allegedly deceptive transactions that permitted the issuer to misstate its financial results. By centering the analysis on the element of reliance, the Court declined to extend private liability to secondary actors whose conduct was not disclosed to the investing public, thereby reinforcing the limits previously articulated in Central Bank of Denver v. First Interstate Bank on aiding-and-abetting liability in private suits.
For law students and practitioners, Stoneridge clarifies the boundaries of so-called scheme liability under Rule 10b-5(a) and (c), the contours of the fraud-on-the-market presumption recognized in Basic v. Levinson, and the importance of public attribution of deceptive conduct to the defendant. The decision also reflects the Court's institutional caution when dealing with implied private rights of action and conveys policy concerns about open-ended securities litigation potentially chilling ordinary business relationships. Its logic later influenced cases like Janus Capital Group v. First Derivative Traders and informs how courts analyze who is a "primary violator" in both private and government enforcement actions.
Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc., 552 U.S. 148 (2008) (U.S. Supreme Court)
Charter Communications, a publicly traded cable company, sought to meet revenue and cash flow targets. It entered into transactions with two of its set-top box vendors, Scientific-Atlanta and Motorola. Charter agreed to overpay approximately $20 per set-top box. In return, the vendors agreed to purchase advertising from Charter in amounts roughly equal to the overpayment. Charter then booked the advertising purchases as revenue while capitalizing the higher set-top box costs, thereby inflating reported revenue and cash flow without a corresponding expense. The vendors documented the transactions as ordinary sales and purchases and did not issue public statements about the arrangement; they did not participate in preparing Charter's financial statements. Investors later alleged the vendors knew the purpose of the arrangement was to allow Charter to misstate its financials and sued the vendors in a private action under Section 10(b) and Rule 10b-5(a), (b), and (c), asserting a theory of scheme liability. The district court dismissed for failure to plead reliance on the vendors' conduct; the Eighth Circuit affirmed. The Supreme Court granted certiorari to decide whether secondary actors who engage in deceptive transactions with an issuer can be held liable in a private 10b-5 action where their conduct was not disclosed to the market.
Can investors maintain a private Section 10(b)/Rule 10b-5 action against secondary actors (such as a supplier or customer) for participating in transactions that enabled an issuer's misstatements, when the secondary actors' deceptive conduct was not publicly disclosed and thus not relied upon by investors?
Section 10(b) of the Securities Exchange Act and Rule 10b-5 prohibit the use of any manipulative or deceptive device or contrivance in connection with the purchase or sale of securities. To state a private Rule 10b-5 claim, a plaintiff must plead and ultimately prove: (1) a material misrepresentation or omission by the defendant; (2) scienter; (3) a connection with the purchase or sale of a security; (4) reliance upon the defendant's deceptive conduct; (5) economic loss; and (6) loss causation. Reliance ensures the requisite causal connection between the defendant's conduct and the plaintiff's injury and may be presumed under Basic's fraud-on-the-market theory only for public misstatements by the defendant or for omissions where the defendant had a duty to disclose. Central Bank holds that private plaintiffs may not recover for aiding and abetting; liability must be primary as to each defendant, and cannot be expanded by recharacterizing aiding-and-abetting as "scheme liability."
No. Investors cannot maintain a private Rule 10b-5 action against the vendors because the investors did not rely on the vendors' own deceptive conduct; their acts were not disclosed to the market and any causal link to the investors' decision to trade was too remote. Extending liability would contravene the reliance requirement and effectively revive aiding-and-abetting liability barred in private suits by Central Bank.
The Court, in an opinion by Justice Kennedy, focused on the reliance element as the critical constraint on the implied private right of action under Section 10(b). The vendors did not publicly make misstatements, nor were their deceptive acts disclosed to the market; therefore, investors could not have relied upon the vendors' conduct. Basic's fraud-on-the-market presumption did not apply because it requires a public statement by the defendant or a duty to disclose; attributing Charter's misstatements to the vendors would impermissibly collapse primary liability into aiding-and-abetting. The Court rejected the argument that investors relied on the vendors' conduct indirectly because the transactions were necessary to Charter's misstatements, finding the causal chain too remote and broken by Charter's independent decision to account for the transactions deceptively. Recognizing a private claim here would allow plaintiffs to end-run Central Bank by pleading that commercial counterparties who engage in ordinary business deals are primary violators whenever an issuer misreports the transactions. The Court also invoked separation-of-powers and policy considerations: the private cause of action is implied rather than express, so courts must avoid enlarging it beyond congressional intent, particularly given the PSLRA's reforms and Congress's decision to authorize the SEC (but not private plaintiffs) to pursue aiding-and-abetting liability under Section 20(e). Expanding liability to undisclosed conduct by secondary actors risked uncertain costs, extraterritorial complications, and chilled legitimate business relationships. Because the vendors had no duty to disclose to investors and did not themselves communicate falsehoods to the market, reliance was not satisfied and the claims failed.
Stoneridge firmly cabins private Rule 10b-5 liability by emphasizing reliance and limiting scheme liability against secondary actors whose conduct was not publicly attributed to them. It complements Central Bank's bar on aiding-and-abetting in private suits and shaped later doctrine, including Janus's definition of who "makes" a statement. For litigants, it underscores that each defendant's own public deceptive conduct must be the object of investor reliance. For transactional lawyers and compliance professionals, it reduces exposure for routine business partners of issuers while still leaving space for SEC enforcement against aiders and abettors. For students, the case is a key study in elements of a 10b-5 claim, the role of implied rights of action, and how policy concerns influence statutory interpretation in securities regulation.
Reliance must be on each defendant's own deceptive conduct that is communicated to, or otherwise affects, the market. The fraud-on-the-market presumption applies only to a defendant's public misstatements (or omissions with a duty to disclose), not to undisclosed actions of secondary actors that merely facilitate an issuer's fraud.
Central Bank barred aiding-and-abetting liability in private Section 10(b) suits; Stoneridge prevents plaintiffs from rebranding aiding-and-abetting as primary 'scheme liability' by insisting on reliance on each defendant's own public conduct. Janus later held that only the person with ultimate authority over a statement 'makes' it for Rule 10b-5(b) purposes, further narrowing private liability to primary violators. Together, they confine private Rule 10b-5 claims to actors who themselves communicate or are responsible for deceptive information reaching investors.
Potentially, yes. If the vendors themselves had made public misstatements, disseminated false information to investors, or if their deceptive acts were publicly attributed in a way that investors could be said to have relied on them, reliance might be satisfied. For example, a vendor that issues its own misleading press release about a transaction or knowingly disseminates false statements to investors could face primary liability, subject to proof of the other elements.
No. Stoneridge concerns private suits. Congress expressly authorized the SEC to bring aiding-and-abetting claims under Exchange Act Section 20(e). The decision underscores that while private plaintiffs cannot sue aiders and abettors, the SEC retains robust enforcement authority against secondary actors who knowingly or recklessly assist a primary violation.
It reduces the risk that ordinary commercial parties—suppliers, customers, and service providers—will face private Rule 10b-5 liability for an issuer's accounting misstatements unless they themselves engage in public deception. Nonetheless, counterparties remain exposed to SEC enforcement and potential liability if they make or disseminate false statements, act with scienter, or otherwise cross the line into primary violations.
Stoneridge crystallizes the central role of reliance in private Rule 10b-5 litigation and sets a high bar for imposing liability on secondary actors. By requiring that investors rely on each defendant's own public deceptive conduct, the Court guarded against transforming private securities fraud suits into broad aiding-and-abetting actions and preserved clear lines between primary and secondary liability.
The decision reflects the Court's broader approach to implied rights of action and securities regulation: deference to congressional design, skepticism of open-ended liability, and sensitivity to policy consequences. For students and practitioners, Stoneridge is indispensable for understanding how reliance constrains scheme liability claims and how securities law balances investor protection with the need for predictable rules governing capital markets and commercial relationships.
Need to cite this case?
Generate a perfectly formatted Bluebook citation in seconds.
Use our Bluebook Citation Generator →